Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02147 | 34486661 | J Nutr | Adverse Maternal Environment and Postweaning Western Diet Alter Hepatic CD36 Expression and Methylation Concurrently with Nonalcoholic Fatty Liver Disease in Mouse Offspring. | 2021 | Details |
| A02148 | 34486133 | J Food Biochem | Regulatory mechanisms of energy metabolism and inflammation in oleic acid-treated HepG2 cells from Lactobacillus acidophilus NX2-6 extract. | 2021 | Details |
| A02149 | 34486129 | Alcohol Clin Exp Res | Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol-associated liver disease. | 2021 | Details |
| A02150 | 34485686 | Mol Ther Oncolytics | Regulatory role and mechanism of m6A RNA modification in human metabolic diseases. | 2021 | Details |
| A02151 | 34485209 | Front Public Health | Awareness, Knowledge, and Misperceptions Related to Nonalcoholic Fatty Liver Disease in a Community Sample of Mexican-Origin Women: A Mixed Methods Study. | 2021 | Details |
| A02153 | 34484560 | Oxid Med Cell Longev | Dietary Valine Ameliorated Gut Health and Accelerated the Development of Nonalcoholic Fatty Liver Disease of Laying Hens. | 2021 | Details |
| A02154 | 34484546 | Radiol Case Rep | Balloon-occluded antegrade transvenous obliteration of rectal varices: A case report. | 2021 | Details |
| A02155 | 34484304 | Front Genet | Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
| A02156 | 34483906 | Front Pharmacol | Metformin Alleviates Steatohepatitis in Diet-Induced Obese Mice in a SIRT1-Dependent Way. | 2021 | Details |
| A02157 | 34482357 | Med Sci Monit | Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02158 | 34482352 | AIDS | Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virus. | 2021 | Details |
| A02159 | 34481473 | BMC Genomics | Proteome analysis identified proteins associated with mitochondrial function and inflammation activation crucially regulating the pathogenesis of fatty liver disease. | 2021 | Details |
| A02160 | 34481454 | BMC Gastroenterol | Impact of dietary compositions and patterns on the prevalence of nonalcoholic fatty liver disease in Japanese men: a cross-sectional study. | 2021 | Details |
| A02161 | 34479550 | BMC Complement Med Ther | Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD rats. | 2021 | Details |
| A02162 | 34479517 | BMC Pediatr | Higher BMI predicts liver fibrosis among obese children and adolescents with NAFLD - an interventional pilot study. | 2021 | Details |
| A02163 | 34479345 | Rev Med Chil | [The role of intestinal microbiota in the development of non-alcoholic fatty liver disease]. | 2021 | Details |
| A02164 | 34478753 | Metabolism | Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk. | 2021 | Details |
| A02165 | 34478730 | Arch Biochem Biophys | Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis. | 2021 | Details |
| A02166 | 34478580 | FASEB J | CELSR2 deficiency suppresses lipid accumulation in hepatocyte by impairing the UPR and elevating ROS level. | 2021 | Details |
| A02167 | 34476902 | Pharmacol Res Perspect | Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study. | 2021 | Details |
| A02168 | 34476138 | Cureus | Chronic Liver Disease: A Mimic of Systemic Lupus Erythematosus. | 2021 | Details |
| A02169 | 34476007 | J Cancer | Research progress, challenges and perspectives on PNPLA3 and its variants in Liver Diseases. | 2021 | Details |
| A02170 | 34475908 | Pak J Med Sci | Frequency of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus and its associated risk factors. | 2022 | Details |
| A02171 | 34475864 | Front Microbiol | Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children. | 2021 | Details |
| A02172 | 34475098 | Diabetes | Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α. | 2021 | Details |
| A02173 | 34475033 | Diabetes Care | Racial and Ethnic Disparities in Comorbidities in Youth With Type 2 Diabetes in the Pediatric Diabetes Consortium (PDC). | 2021 | Details |
| A02174 | 34474519 | Endocrinol Metab (Seoul) | Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability. | 2021 | Details |
| A02175 | 34474517 | Endocrinol Metab (Seoul) | Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts. | 2021 | Details |
| A02176 | 34473644 | Aging (Albany NY) | Activation of the gut microbiota-kynurenine-liver axis contributes to the development of nonalcoholic hepatic steatosis in nondiabetic adults. | 2021 | Details |
| A02177 | 34473596 | Can J Physiol Pharmacol | Hepatoprotective effect of trypsin/chymotrypsin against olanzapine-induced non-alcoholic steatohepatitis in rats. | 2021 | Details |
| A02178 | 34473313 | Methods Mol Biol | Therapeutic Effects of Resveratrol on Nonalcoholic Fatty Liver Disease Through Inflammatory, Oxidative Stress, Metabolic, and Epigenetic Modifications. | 2022 | Details |
| A02179 | 34472683 | Hepatol Res | MAFLD: Renovation of clinical practice and disease awareness of fatty liver. | 2021 | Details |
| A02180 | 34472680 | Diabetes Obes Metab | Associations of weight loss with obesity-related comorbidities in a large integrated health system. | 2021 | Details |
| A02181 | 34471049 | Biol Pharm Bull | Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist. | 2021 | Details |
| A02182 | 34470993 | J Toxicol Sci | Resveratrol reverses the programmed high-susceptibility to non-alcoholic fatty liver disease by targeting the hepatic SIRT1-SREBP1c pathway in prenatal ethanol-exposed rat offspring. | 2021 | Details |
| A02183 | 34470931 | Nihon Yakurigaku Zasshi | [Development of liver organoids from NASH model mice and their application to drug discovery]. | 2021 | Details |
| A02184 | 34470675 | Br J Nutr | Diet containing dehulled adlay ameliorates hepatic steatosis, inflammation and insulin resistance in rats with non-alcoholic fatty liver disease. | 2021 | Details |
| A02185 | 34469884 | Dig Dis | Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm. | 2021 | Details |
| A02186 | 34469716 | Cell Rep | Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota. | 2021 | Details |
| A02187 | 34469404 | J Clin Gastroenterol | Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease: A Review of the Literature With Recommendations. | 2021 | Details |
| A02188 | 34467980 | J Clin Endocrinol Metab | Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study. | 2022 | Details |
| A02189 | 34467835 | Br J Nutr | Cardiometabolic traits mediated the relationship from early life famine exposure to adulthood nonalcoholic fatty liver disease risk. | 2021 | Details |
| A02190 | 34466796 | JHEP Rep | Determining a healthy reference range and factors potentially influencing PRO-C3 - A biomarker of liver fibrosis. | 2021 | Details |
| A02191 | 34466334 | Cureus | Effective Treatment of Nonalcoholic Fatty Liver Disease Using a Community-Based Weight Management Program. | 2021 | Details |
| A02192 | 34466320 | Cureus | The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02193 | 34466067 | Saudi J Biol Sci | Prevalence and predictors of non-alcoholic fatty liver disease in tertiary care hospital of Taif, Saudi Arabia: A retrospective study. | 2021 | Details |
| A02194 | 34465857 | Int J Obes (Lond) | Obese mice weight loss role on nonalcoholic fatty liver disease and endoplasmic reticulum stress treated by a GLP-1 receptor agonist. | 2021 | Details |
| A02195 | 34465807 | Sci Rep | Close association between non-alcoholic fatty liver disease and ossification of the posterior longitudinal ligament of the spine. | 2021 | Details |
| A02196 | 34464909 | Diabetes Metab Syndr | Retrospective analysis (2009-2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India. | 2021 | Details |
| A02197 | 34464720 | Clin Gastroenterol Hepatol | Serum Biomarkers are Associated With Atherosclerotic Cardiovascular Disease Among Patients With Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography. | 2021 | Details |
| A02199 | 34463983 | Periodontol 2000 | Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis. | 2021 | Details |
| A02200 | 34463867 | Semin Immunopathol | Functional heterogeneity of CD4+ T cells in liver inflammation. | 2021 | Details |
| A02201 | 34462492 | Sci Rep | Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems. | 2021 | Details |
| A02202 | 34461919 | Lipids Health Dis | Low serum Maresin-1 levels are associated with non-alcoholic fatty liver disease: a cross-sectional study. | 2021 | Details |
| A02203 | 34461916 | Environ Health | Associations of acrylamide with non-alcoholic fatty liver disease in American adults: a nationwide cross-sectional study. | 2021 | Details |
| A02204 | 34461220 | Pharmacol Res | Identification of the anti-fungal drug fenticonazole nitrate as a novel PPARγ-modulating ligand with good therapeutic index: Structure-based screening and biological validation. | 2021 | Details |
| A02206 | 34461107 | Exp Cell Res | MIG/CXCL9 exacerbates the progression of metabolic-associated fatty liver disease by disrupting Treg/Th17 balance. | 2021 | Details |
| A02208 | 34459959 | Eur J Pediatr | Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial. | 2021 | Details |
| A02209 | 34459761 | Wiad Lek | ASSOCIATION ANALYSIS OF PIOGLITAZONE EFFECTIVENESS IN TREATMENT OF NAFLD PATIENTS WITH OBESITY AND PPARG RS1801282 (PRO12ALA) GENOTYPE. | 2021 | Details |
| A02210 | 34459531 | EMBO Rep | p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth. | 2021 | Details |
| A02211 | 34459096 | Liver Int | Changing clinical management of NAFLD in Asia. | 2021 | Details |
| A02212 | 34459004 | J Food Biochem | Chlorella vulgaris is an effective supplement in counteracting non-alcoholic fatty liver disease-related complications through modulation of dyslipidemia, insulin resistance, and inflammatory pathways. | 2021 | Details |
| A02213 | 34458376 | J Immunol Res | Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway. | 2021 | Details |
| A02214 | 34456873 | Front Endocrinol (Lausanne) | Purinergic Signaling in Liver Pathophysiology. | 2021 | Details |
| A02215 | 34456869 | Front Endocrinol (Lausanne) | Free Triiodothyronine Is Associated With Hepatic Steatosis and Liver Stiffness in Euthyroid Chinese Adults With Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02216 | 34456329 | Med Sci Monit | A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health. | 2021 | Details |
| A02217 | 34455909 | Autophagy | Impairment of ULK1 sulfhydration-mediated lipophagy by SREBF1/SREBP-1c in hepatic steatosis. | 2021 | Details |
| A02219 | 34455284 | Curr Opin Pharmacol | An update on drug development for the treatment of metabolic (dysfunction) associated fatty liver disease: Progress and opportunities. | 2021 | Details |
| A02220 | 34455040 | Free Radic Biol Med | Mitochondrial dysfunction in mouse livers depleted of iron chaperone PCBP1. | 2021 | Details |
| A02221 | 34454994 | J Hepatol | Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population. | 2021 | Details |
| A02222 | 34454951 | J Pediatr | Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02223 | 34454176 | Biochem Biophys Res Commun | Translatome analysis reveals the regulatory role of betaine in high fat diet (HFD)-induced hepatic steatosis. | 2021 | Details |
| A02224 | 34453963 | J Hepatol | Epidemiology and risk-stratification of NAFLD-associated HCC. | 2021 | Details |
| A02225 | 34453940 | Life Sci | Pancreastatin induces hepatic steatosis in type 2 diabetes by impeding mitochondrial functioning. | 2021 | Details |
| A02226 | 34453689 | Obes Surg | Correlation Between Sex Hormones and Non-alcoholic Fatty Liver Disease Before and After Laparoscopic Sleeve Gastrectomy. | 2021 | Details |
| A02227 | 34453648 | J Med Ultrason (2001) | The most appropriate region-of-interest position for attenuation coefficient measurement in the evaluation of liver steatosis. | 2021 | Details |
| A02228 | 34453359 | Hepatology | Metabolic dysfunction-associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study. | 2021 | Details |
| A02229 | 34453237 | J Med Ultrason (2001) | Quantitative assessment of fatty liver using ultrasound attenuation imaging. | 2021 | Details |
| A02230 | 34453120 | Lab Invest | Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH. | 2021 | Details |
| A02231 | 34453052 | Nat Commun | The pesticide chlorpyrifos promotes obesity by inhibiting diet-induced thermogenesis in brown adipose tissue. | 2021 | Details |
| A02232 | 34450627 | J Mol Cell Biol | Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascades. | 2021 | Details |
| A02233 | 34450307 | Pharmacol Res | Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis. | 2021 | Details |
| A02234 | 34450194 | Prog Lipid Res | PARPs in lipid metabolism and related diseases. | 2021 | Details |
| A02235 | 34450119 | Exp Cell Res | miR-23b Ameliorates nonalcoholic steatohepatitis by targeting Acyl-CoA thioesterases 4. | 2021 | Details |
| A02236 | 34449924 | Hepatology | S-adenosylmethionine inhibits la ribonucleoprotein domain family member 1 in murine liver and human liver cancer cells. | 2021 | Details |
| A02237 | 34449768 | PLoS One | Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians. | 2021 | Details |
| A02238 | 34449492 | Medicine (Baltimore) | Gut-flora metabolites is not associated with synchronous carotid artery plaque and non-alcoholic fatty liver disease in asymptomatic adults: A STROBE-compliant article. | 2021 | Details |
| A02239 | 34449489 | Medicine (Baltimore) | Association between higher pericoronary adipose tissue attenuation measured by coronary computed tomography angiography and nonalcoholic fatty liver disease: A matched case-control study. | 2021 | Details |
| A02240 | 34449316 | Biomed Pharmacother | Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A02241 | 34449139 | Turk J Pediatr | The performance of shear wave elastography on evaluating liver changes in obese and overweight children. | 2021 | Details |
| A02242 | 34448598 | Metab Syndr Relat Disord | Non-Alcoholic Steatohepatitis Severity Associates with FGF21 Level and Kidney Glucose Uptake. | 2021 | Details |
| A02243 | 34448436 | J Histochem Cytochem | Independent of Calorie Intake, Short-term Alternate-day Fasting Alleviates NASH, With Modulation of Markers of Lipogenesis, Autophagy, Apoptosis, and Inflammation in Rats. | 2021 | Details |
| A02244 | 34447968 | J Anim Sci Technol | Effect of ciglitazone on adipogenic transdifferentiation of bovine skeletal muscle satellite cells. | 2021 | Details |
| A02245 | 34447812 | World J Clin Cases | Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis. | 2021 | Details |
| A02246 | 34447677 | J Clin Transl Hepatol | Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2021 | Details |
| A02247 | 34447378 | Front Immunol | Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression. | 2021 | Details |
| A02248 | 34447235 | World J Gastroenterol | Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. | 2021 | Details |
| A02249 | 34446693 | Cell Death Dis | Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1/AMPK signaling through targeting miR-206. | 2021 | Details |
| A02250 | 34446275 | Maturitas | The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause. | 2021 | Details |
| A02251 | 34446271 | Clin Ther | Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. | 2021 | Details |